US 9878006
Treatment of obesity and obesity related disorders by pharmalogical targeting of Kv1.3 potassium channels
granted A61KA61K38/00A61K38/16
Quick answer
US patent 9878006 (Treatment of obesity and obesity related disorders by pharmalogical targeting of Kv1.3 potassium channels) held by The Regents of the University of California expires Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jan 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K38/00, A61K38/16, A61K38/17, A61K38/1767